Top Marijuana Shares in the NASDAQ

Top Marijuana Shares in the NASDAQ

Even though greater part of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade on the countertop (OTC), a couple of cannabis companies are traded regarding the NASDAQ. Some investors choose stocks which are noted on the NASDAQ with other exchanges because of their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For instance, given that cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to a professional U.S. change is now a banner achievement for a lot of marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

pure cbd oil for sale

An increasing wide range of cannabis organizations are increasingly being noted on reputable U.S. exchanges in the place of being exchanged from the OTC market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ was 1st exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis businesses regarding the NASDAQ mirror this, plus the most of them run when you look at the area that is biotech of industry. Here you will find the NASDAQ-listed marijuana shares, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech business active in the manufacturing of medical cannabis medications. Research and development around Arena’s APD371 could be the main focus for the firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a blank check business that is in a merger agreement with Kalyx developing Inc. Kalyx is a number one investment rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, specially the section of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis has been utilized in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
  • Organizations may also be developing cannabinoid items for autism range disorders, schizophrenia, glioma, Tourette syndrome, epileptic problems, Prader-Willi Syndrome (an inherited condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although every one of the firm’s clinical-stage items target opioid receptors, Cara happens to be performing preclinical research on cannabinoids for the treating neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and manufacturing are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, as well as other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really a cannabis that are canadian. The team owns and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro maker Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra cash to invest in its continued expansion but in addition with a partner that is well-established within the marketing of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis company. It distributes a variety of cannabis usage accessories and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs e-commerce web sites for extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is creating a portfolio of cannabinoid medications. These medicines include Sativex for the treatment of spasticity pertaining to multiple sclerosis and cancer discomfort and Epidiolex to treat childhood epilepsy. Sativex is commercialized much more compared to a dozen nations outside of the united states of america and has now gotten regulatory approval in various other countries. Epidiolex received Food And Drug Administration approval being a treatment for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early beginning epilepsy without good current treatments. Other indications show that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical business that is developing medications according to its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant wellness services and products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate to be used on cannabis plants into the Ca cultivation market.

Modern Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is a manufacturer of beverages based on yerba mate, green tea extract, kombucha, and comparable products. In current months, modern age has expanded its beverage offerings to include CBD infusions aswell, bringing it in to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, which makes it probably the most current cannabis businesses to record from the popular change. The business was quickly expanding its manufacturing capacity that will have the ability to create up to 113,000 kilograms of item per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs when you look at the enforcement sector. The business’s business operations support medication assessment through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a brief cost boost) whenever it announced the production of a unique Palmetto make of recreational cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical business concentrated in the growth of cannabinoid-based medications. Therapix’s present pipeline includes items targeted for the treatment of Tourette problem and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being 1st company that is marijuana-related have a preliminary general public providing (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Global is one of current cannabis stock to begin trading on the NASDAQ. The business’s stocks became readily available for trade on 21, 2019 february. The business features a decades-long history in greenhouse produce manufacturing and contains only recently shifted a few of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted regarding the growth of artificial treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.

Trả lời

Thư điện tử của bạn sẽ không được hiển thị công khai. Các trường bắt buộc được đánh dấu *